{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:57:54Z","timestamp":1740142674045,"version":"3.37.3"},"reference-count":15,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.64.06.484","type":"journal-article","created":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T15:05:27Z","timestamp":1538838327000},"page":"484-491","source":"Crossref","is-referenced-by-count":2,"title":["Spinal muscular atrophy 5Q \u2013 Treatment with nusinersen"],"prefix":"10.1590","volume":"64","author":[{"given":"Antonio","family":"Silvinato","sequence":"first","affiliation":[{"name":"Brazilian Medical Association,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-5207","authenticated-orcid":false,"given":"Wanderley M","family":"Bernardo","sequence":"additional","affiliation":[{"name":"Brazilian Medical Association,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2018,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0883073807305673","article-title":"Spinal muscular atrophy: clinical classifications and disease heterogeneity","volume":"22","author":"Russman BS","year":"2007","journal-title":"J Child Neurol."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0883073807305664","article-title":"Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling","volume":"22","author":"Shanmugarajan S","year":"2007","journal-title":"J Child Neurol."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy","volume":"377","author":"Finkel RS","year":"2017","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review","volume":"12","author":"Verhaart IEC","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/0883073807305668","article-title":"Spinal muscular atrophy diagnostics","volume":"22","author":"Prior TW","year":"2007","journal-title":"J Child Neurol."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1172-6-71","article-title":"Spinal muscular atrophy","volume":"6","author":"D'Amico A","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jmg.33.4.281","article-title":"Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease","volume":"33","author":"Burlet P","year":"1996","journal-title":"J Med Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.spen.2006.06.008","article-title":"Spinal muscular atrophy: from gene to therapy","volume":"13","author":"Wirth B","year":"2006","journal-title":"Semin Pediatr Neurol."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","article-title":"Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications","volume":"52","author":"Zerres K","year":"1995","journal-title":"Arch Neurol."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0883073807305673","article-title":"Spinal muscular atrophy: clinical classifications and disease heterogeneity","volume":"22","author":"Russman BS","year":"2007","journal-title":"J Child Neurol."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy","volume":"378","author":"Mercuri E","year":"2018","journal-title":"N Engl J Med"},{"series-title":"Levels of Evidence and Grades of Recommendations - Oxford Centre for Evidence Based Medicine","key":"ref12"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad AR","year":"1996","journal-title":"Control Clin Trials"},{"series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells G","key":"ref14"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jebm.12018","article-title":"Understanding GRADE: an introduction","volume":"6","author":"Goldet G","year":"2013","journal-title":"J Evid Based Med"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ramb\/v64n6\/1806-9282-ramb-64-06-0484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T09:41:23Z","timestamp":1542015683000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302018000600484&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["S0104-42302018000600484"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.64.06.484","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"type":"electronic","value":"1806-9282"},{"type":"print","value":"0104-4230"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}